rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2006-10-30
|
pubmed:abstractText |
The homozygous presence of the arginine-16 variant of the beta(2) adrenoceptor gene ADRB2 reverses the benefits from the regular use of short acting beta(2) agonists in asthmatic adults compared with the homozygous glycine-16 genotype. We studied the effect of this polymorphic variation on asthma exacerbations in children and young adults and its relation to long acting beta(2) agonists.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-10427938,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-10669529,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-10686044,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-10950895,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-11586955,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-12379546,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-12653493,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-12775861,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-14678342,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-15003036,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-15080825,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-15500895,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-15527481,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-16199708,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-16322642,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-17071831,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-18511645,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-514716,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16772309-9808539
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0040-6376
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
940-4
|
pubmed:dateRevised |
2010-9-15
|
pubmed:meshHeading |
pubmed-meshheading:16772309-Adolescent,
pubmed-meshheading:16772309-Adrenergic beta-Agonists,
pubmed-meshheading:16772309-Albuterol,
pubmed-meshheading:16772309-Arginine,
pubmed-meshheading:16772309-Asthma,
pubmed-meshheading:16772309-Child,
pubmed-meshheading:16772309-Cross-Sectional Studies,
pubmed-meshheading:16772309-Female,
pubmed-meshheading:16772309-Genetic Predisposition to Disease,
pubmed-meshheading:16772309-Genotype,
pubmed-meshheading:16772309-Humans,
pubmed-meshheading:16772309-Male,
pubmed-meshheading:16772309-Receptors, Adrenergic, beta-2,
pubmed-meshheading:16772309-Scotland
|
pubmed:year |
2006
|
pubmed:articleTitle |
Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol.
|
pubmed:affiliation |
Asthma and Allergy Research Group, Division of Medicine and Therapeutics, Ninewells Hospital, Dundee, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|